Table II.
Fungal culture results from persons with suspected tinea capitis in a large national commercial laboratory dataset, by result—United States, March 1, 2019 to October 31, 2022*
| All results | Dermatophytes | Nondermatophyte molds | Yeasts | Unspecified fungus | |
|---|---|---|---|---|---|
|
|
|
||||
| Feature | No. positive/No. tested (%) | No. (%), among positive results | |||
|
| |||||
| Age group, years (n = 20,209) | |||||
| 0–2 | 686/2051 (33.4) | 474 (69.1) | 88 (12.8) | 80 (11.7) | 44 (6.4) |
| 3–12 | 5285/12,188 (43.4) | 3992 (75.5) | 456 (8.6) | 423 (8.0) | 414 (7.8) |
| 13–21 | 428/2437 (17.6) | 201 (47.0) | 73 (17.1) | 107 (25) | 47 (11.0) |
| >21 | 638/3533 (18.1) | 193 (30.3) | 187 (29.3) | 149 (23.4) | 109 (17.1) |
| Sex (n = 20,001) | |||||
| Male | 4273/10,697 (39.9) | 3098 (72.5) | 446 (10.4) | 412 (9.6) | 317 (7.4) |
| Female | 2694/9304 (29.0) | 1718 (63.8) | 345 (12.8) | 338 (12.5) | 293 (10.9) |
| US census region (n = 20,253) | |||||
| South | 4548/13,218 (34.4) | 3026 (66.5) | 573 (12.6) | 473 (10.4) | 476 (10.5) |
| Northeast | 1693/4779 (35.4) | 1250 (73.8) | 148 (8.7) | 221 (13.1) | 74 (4.4) |
| West | 413/1318 (31.3) | 289 (70.0) | 45 (10.9) | 45 (10.9) | 34 (8.2) |
| Midwest | 389/938 (41.5) | 297 (76.3) | 38 (9.8) | 24 (6.2) | 30 (7.7) |
| Provider type (n = 17,060) | |||||
| Dermatology | 2147/7393 (29.0) | 1272 (59.2) | 351 (16.3) | 297 (13.8) | 227 (10.6) |
| Pediatrics | 2341/6074 (38.5) | 1735 (74.1) | 223 (9.5) | 242 (10.3) | 141 (6) |
| Family, general practice, internal medicine | 880/2238 (39.3) | 620 (70.5) | 92 (10.5) | 74 (8.4) | 94 (10.7) |
| Other | 553/1355 (40.8) | 414 (74.9) | 48 (8.7) | 48 (8.7) | 43 (7.8) |
| Total | 7046/20,259 (34.8) | 4864 (69.0) | 804 (11.4) | 763 (10.8) | 615 (8.7) |
*
This period represents the widest range of available data.